Inter‐rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa
Linnea Thorlacius(Frederiksberg Hospital), Gregor B. E. Jemec(Gentofte Hospital), Christos C. Zouboulis(Freie Universität Berlin), Robin Christensen(University of Copenhagen), Peter Theut Riis(University of Copenhagen), Sabrina Mai Nielsen(University of Southern Denmark), Karin Sartorius(Stockholm South General Hospital), John R Ingram(Cardiff University), Łukasz Matusiak(Wrocław University of Science and Technology), Amit Garg(Northwell Health), Alice B. Gottlieb(The University of Texas Southwestern Medical Center), V. del Mármol(Université Libre de Bruxelles), J.C. Pascual(Hospital General Universitario de Alicante Doctor Balmis), Ditte Marie Lindhardt Saunte(University of Copenhagen), Hessel H. van der Zee(Erasmus MC), Vincenzo Bettoli(University of Ferrara), J. Revuz(Hidradenitis Suppurativa Foundation), Thrasyvoulos Tzellos(Nordland Hospital Trust)
Cited by 73
Related Papers
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
|Journal of the European Academy of Dermatology and Venereology|2015|1.1k
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
|The Lancet|2007|1.1k
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
|Journal of Investigative Dermatology|2014|954
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
|Journal of the American Academy of Dermatology|2019|917
Psoriasis
|Nature Reviews Disease Primers|2016|893